Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants - Nature.com
VisMederi S.r.l, Siena, ItalyVisMederi Research S.r.l., Siena, ItalyDepartment of Medical Sciences, Infectious and Tropical Diseases Unit, Siena University Hospital, Siena, ItalyDepartment of Medical Biotechnologies, University of Siena, Siena, ItalyDepartment of Molecular and Developmental Medicine, University of Siena, Siena, ItalyDepartment of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, ItalyYou can also search for this author inYou can also search for this author inYou can also search for this author inYou can also search for this author inYou can also search for this author inYou can also search for this author inYou can also search for this author inYou can also search for this author inYou can also search for this author inYou can also search for this author inYou can also search for this author inYou can also search for this author inYou can also search for this author inYou can also search for this author inYou can also search for this author inYou can also search for this author in